Important pharmacy news and late-breaking industry information updated daily.

FDA announced Monday that it has approved nine applications for the generic versions of pregabalin (Lyrica—Pfizer) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients aged 17 years a

Cities, towns, and counties on Friday filed thousands of documents from corporations across the pharmaceutical supply chain as they laid out a detailed case of how diverse interests fed an opioid epidemic that persisted for nearly 2 decades.